NCT07169851 2026-03-06
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Eli Lilly and Company
Phase 2 Recruiting
Clinical Trials
11 trialsNCT07403370 2026-02-11
Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis
Shandong Cancer Hospital and Institute
Recruiting
NCT03118986 2025-10-08
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy
The Hospital for Sick Children
Phase 2 Recruiting
NCT06904235 2025-07-28
Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)
Helsinn Healthcare SA
Phase 2 Recruiting
NCT07038551 2025-07-02
Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study
International University of Health and Welfare
Phase 4 Recruiting
NCT06200168 2025-04-02
Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer
Affiliated Hospital of Qinghai University
Phase 3 Recruiting
NCT06588413 2024-11-22
FONDO-LOW
Augusta University
Phase 3 Recruiting
NCT05838638 2024-05-16
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
University of Central Florida
Phase NA Recruiting
NCT06314906 2024-03-21
Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
Lanzhou University Second Hospital
Phase 3 Recruiting
NCT06017284 2023-11-24
PTCA199-5
Fudan University
Phase 3 Recruiting
NCT05690802 2023-01-19
TSEPHCC
Xijing Hospital
Phase NA Recruiting